日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

High In Vitro and In Vivo Activity of BI-847325, a Dual MEK/Aurora Kinase Inhibitor, in Human Solid and Hematologic Cancer Models

BI-847325(一种双重MEK/Aurora激酶抑制剂)在人类实体瘤和血液肿瘤模型中表现出较高的体外和体内活性

Vuaroqueaux, Vincent; Musch, Alexandra; Peille, Anne-Lise; Kelter, Gerhard; Weichert, Loreen; Metz, Thomas; Hendriks, Hans R; Fiebig, Heinz-Herbert

Pharmacogenomics characterization of the MDM2 inhibitor MI-773 reveals candidate tumours and predictive biomarkers.

MDM2抑制剂MI-773的药物基因组学特征分析揭示了候选肿瘤和预测性生物标志物

Vuaroqueaux Vincent, Hendriks Hans R, Al-Hasani Hoor, Peille Anne-Lise, Das Samayita, Fiebig Heinz-Herbert

Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models

CP-4126(吉西他滨的脂肪酸衍生物)在体外和体内肿瘤模型中的抗增殖活性、作用机制和口服抗肿瘤活性

Bergman, Andries M; Adema, Auke D; Balzarini, Jan; Bruheim, Skjalg; Fichtner, Iduna; Noordhuis, Paul; Fodstad, Oystein; Myhren, Finn; Sandvold, Marit L; Hendriks, Hans R; Peters, Godefridus J